Boris Minev
Directeur Technique/Scientifique/R&D chez CALI BIOTPAR
Fortune : 84 892 $ au 30/06/2024
Profil
Boris Minev is currently the Chief Medical Officer & President-Medical Affairs at Calidi Biotherapeutics, Inc. He previously worked as the Director-Immunotherapy & Translational Oncology at Genelux Corp.
from 2010 to 2015, and as the Director-Tumor Immunology & Immunotherap at UCSD Moores Cancer Center from 2000 to 2015.
Dr. Minev holds a doctorate degree from Medical University Sofia.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 17/06/2024 | 424 458 ( 0,66% ) | 84 892 $ | 30/06/2024 |
Postes actifs de Boris Minev
| Sociétés | Poste | Début |
|---|---|---|
| CALI BIOTPAR | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de Boris Minev
| Sociétés | Poste | Fin |
|---|---|---|
| GENELUX CORPORATION | Corporate Officer/Principal | 01/06/2015 |
UCSD Moores Cancer Center
 UCSD Moores Cancer Center Miscellaneous Commercial ServicesCommercial Services Part of University of California, UCSD Moores Cancer Center provides clinical and medical research services for cancer treatment. The company is based in La Jolla, CA. | Corporate Officer/Principal | 01/06/2015 |
Formation de Boris Minev
| Medical University Sofia | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| CALI BIOTPAR | Health Technology |
| GENELUX CORPORATION | Health Technology |
| Entreprise privées | 1 |
|---|---|
UCSD Moores Cancer Center
UCSD Moores Cancer Center Miscellaneous Commercial ServicesCommercial Services Part of University of California, UCSD Moores Cancer Center provides clinical and medical research services for cancer treatment. The company is based in La Jolla, CA. | Commercial Services |
